Scott A. Yerby Sells 648 Shares of SI-Bone Inc (NASDAQ:SIBN) Stock
SI-Bone Inc (NASDAQ:SIBN) insider Scott A. Yerby sold 648 shares of the company’s stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $19.01, for a total value of $12,318.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
NASDAQ:SIBN opened at $19.65 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 12.70 and a current ratio of 13.06. The stock’s fifty day moving average price is $17.84. SI-Bone Inc has a 52 week low of $14.08 and a 52 week high of $23.03.
SI-Bone (NASDAQ:SIBN) last announced its quarterly earnings data on Wednesday, May 8th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.13). The firm had revenue of $14.99 million during the quarter. As a group, analysts anticipate that SI-Bone Inc will post -1.45 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently made changes to their positions in SIBN. Orbimed Advisors LLC acquired a new stake in shares of SI-Bone in the fourth quarter valued at $20,584,000. RTW Investments LP acquired a new stake in shares of SI-Bone in the fourth quarter valued at $16,802,000. BlackRock Inc. acquired a new stake in shares of SI-Bone in the fourth quarter valued at $15,835,000. Pura Vida Investments LLC purchased a new position in SI-Bone in the fourth quarter valued at $4,485,000. Finally, Federated Investors Inc. PA increased its holdings in SI-Bone by 111.4% in the first quarter. Federated Investors Inc. PA now owns 370,000 shares of the company’s stock valued at $6,971,000 after buying an additional 195,000 shares during the last quarter. Institutional investors and hedge funds own 38.89% of the company’s stock.
SI-Bone Company Profile
SI-BONE, Inc, a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.
See Also: Bear Market
Receive News & Ratings for SI-Bone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-Bone and related companies with MarketBeat.com's FREE daily email newsletter.